AbbVie presents nine-year venetoclax trial results at EHA congress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to AbbVie presents nine-year venetoclax trial results at EHA congress
AbbVie (NYSE: ABBV) Delayed: 234.76 +4.75 (2.07%)
Previous Close $230.01    52 Week High $68.12 
Open $232.97    52 Week Low $50.71 
Day High $235.31    P/E 50.92 
Day Low $231.30    EPS $4.61 
Volume 7,492,800